Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn—a prospective randomized controlled trial
- 6 October 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 170 (4), 461-467
- https://doi.org/10.1007/s00431-010-1310-8
Abstract
Phototherapy is the standard treatment in moderately severe hemolytic disease of newborn (HDN), whereas exchange transfusion (ET) is the second line in progressive cases. Intravenous immunoglobin (IVIG) has been suggested to decrease the need for ET. We aimed at assessing the efficacy of early two-dose regimens of IVIG to avoid unnecessary ET in severe Rh HDN. The study included 90 full-term neonates with Rh incompatibility unmodified by antenatal treatment and not eligible for early ET and which were randomly assigned into one of three groups: group (I), treated by conventional method; groups IIa and IIb received IVIG once at 12 h postnatal age if PT was indicated, in a dose of 0.5 and 1 g/kg, respectively. Analysis revealed 11 neonates (22%) in the conventional group and 2 (5%) in the intervention group who administered low-dose IVIG at 12 h, while none in group IIb required exchange transfusion (p = 0.03). Mean bilirubin levels were significantly lower during the first 96 h in the intervention group compared to the conventional group (p < 0.0001). Shorter duration of phototherapy (52.8 ± 12.39 h) and hospital stay (3.25 ± 0.71 days) in the IVIG group compared to conventional group (84 ± 12.12 h and 4.72 ±0.78 days, p < 0.0001, respectively) were observed. We conclude that IVIG administration at 12 h was effective in the treatment of severe Rh HDN; the low-dose IVIG (0.5 g/kg) was as effective as high dose (1 g/kg) in reducing the duration of phototherapy and hospital stay, but less effective in avoiding exchange transfusion.This publication has 33 references indexed in Scilit:
- Intravenous Immune Globulin: Clinical Applications in the NewbornNeoReviews, 2010
- Survey of management of neonatal haemolytic jaundice in AustralasiaJournal of Paediatrics and Child Health, 2010
- Intravenous Immunoglobulin and Necrotizing Enterocolitis in Newborns With Hemolytic DiseasePEDIATRICS, 2010
- Prise en charge périnatale et devenir neurologique à moyen terme des nouveau-nés hospitalisés pour maladie hémolytique par immunisation anti-DGynécologie Obstétrique & Fertilité, 2008
- Management of Rhesus Alloimmunization in PregnancyObstetrics & Gynecology, 2008
- Haemolytic disease of the newbornArchives of Disease in Childhood: Fetal & Neonatal, 2007
- Fetal Intravenous Immunoglobulin Therapy in Rhesus Hemolytic DiseaseGynecologic and Obstetric Investigation, 2006
- Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newbornThe Journal of Maternal-Fetal & Neonatal Medicine, 2004
- Recent Developments in the Management of Neonatal HyperbilirubinemiaNeoReviews, 2000
- Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic diseasejpme, 1995